Clinical Trial Update: Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

View source ↗

Summary

A pooled analysis of single-arm studies evaluating Budesonide/Glycopyrronium/Formoterol (BGF) used in routine COPD care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Budesonide/Glycopyrronium/Formoterol (budesonide/glycopyrronium/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Pulmonary Disease, Chronic Obstructive | Status: RECRUITING